Basic | |
---|---|
Market Cap | $16.66B |
Price | $268.77 |
52 Week Range | 160.19-279.4 |
Beta | 1.22 |
Margins | |
Gross Profit Margin | 76.27% |
Operating Profit Margin | 17.84% |
Net Profit Margin | 23.22% |
Valuation (TTM) | |
P/E Ratio | 44.82 |
Price to Sales Ratio | 10.41 |
Price to Book Ratio | 16.87 |
PEG Ratio | 6.38 |
Medical - Devices
Healthcare
3,000
2007-05-15T00:00:00.000Z
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
978 600 7000
100 Nagog Park, Acton, MA, 01720, US
0001145197